Valuation: ABL Bio Inc.

Capitalization 10,27400Cr 705.91Cr 593.18Cr 540.82Cr 516.44Cr 955.6Cr 64TCr 998.3Cr 6.28TCr 2.5TCr 31TCr 2.65TCr 2.59TCr 1,08900Cr P/E ratio 2025 *
-21,859x
P/E ratio 2026 * -326x
Enterprise value 1.01TCr 69.61L 58.49L 53.33L 50.93L 94.23L 63Cr 98.44L 6.19Cr 2.47Cr 30Cr 2.61Cr 2.56Cr 107.35Cr EV / Sales 2025
139x
EV / Sales 2026 * 132x
Free-Float
69.56%
Yield 2025 *
-
Yield 2026 * -
1 day-1.80%
1 week-7.79%
Current month-6.02%
1 month-9.14%
3 months+84.88%
6 months+149.40%
Current year-7.10%
1 week 1,74,100
Extreme 174100
1,97,500
1 month 1,72,200
Extreme 172200
2,57,500
Current year 1,72,200
Extreme 172200
2,57,500
1 year 31,300
Extreme 31300
2,57,500
3 years 15,370
Extreme 15370
2,57,500
5 years 15,370
Extreme 15370
2,57,500
10 years 12,250
Extreme 12250
2,57,500
Manager TitleAgeSince
Chief Executive Officer 63 16/02/2016
Director of Finance/CFO 56 -
Director TitleAgeSince
Director/Board Member 63 16/02/2016
Director/Board Member 56 -
Director/Board Member 54 30/03/2023
Change 5d. change 1-year change 3-years change Capi.($)
-1.80%-7.79%+370.38%+776.42% 705.91Cr
-1.86%-3.09%+12.27%+99.20% 5.16TCr
+0.78%+7.97%+74.30%+13.78% 4.39TCr
-1.72%-3.28%+84.55%+643.49% 3.17TCr
-0.97%-0.60%-5.57%-24.39% 2.73TCr
+3.45%+13.24%+93.46%-35.86% 2.12TCr
-2.97%-5.51%+38.18%-30.35% 1.9TCr
+0.18%+3.60%+146.48% - 1.3TCr
-0.47%+2.43%+69.68%+135.61% 1.25TCr
-1.62%-0.06%+29.91%+140.96% 1.16TCr
Average -0.75%+1.06%+91.36%+190.98% 2.39TCr
Weighted average by Cap. -0.71%+0.80%+62.23%+145.75%

Financials

2025 2026 *
Net sales 8.88TCr 6.1Cr 5.12Cr 4.67Cr 4.46Cr 8.26Cr 552.29Cr 8.62Cr 54Cr 22Cr 266.08Cr 23Cr 22Cr 940.41Cr 7.67TCr 5.27Cr 4.43Cr 4.04Cr 3.86Cr 7.14Cr 477.38Cr 7.45Cr 47Cr 19Cr 229.99Cr 20Cr 19Cr 812.84Cr
Net income -225Cr -15.46L -12.99L -11.84L -11.31L -20.93L -14Cr -21.86L -1.37Cr -54.78L -6.75Cr -57.99L -56.79L -24Cr -2.25TCr -1.55Cr -1.3Cr -1.18Cr -1.13Cr -2.09Cr -140Cr -2.19Cr -14Cr -5.48Cr -67Cr -5.8Cr -5.68Cr -238.39Cr
Net Debt -14TCr -9.79Cr -8.23Cr -7.5Cr -7.17Cr -13Cr -886.99Cr -14Cr -87Cr -35Cr -427.33Cr -37Cr -36Cr -1.51TCr -16TCr -11Cr -9.22Cr -8.41Cr -8.03Cr -15Cr -993.71Cr -16Cr -98Cr -39Cr -478.75Cr -41Cr -40Cr -1.69TCr
Logo ABL Bio Inc.
ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.
Employees
102
Date Price Change Volume
11/26/11 1,87,000.00 +0.65% 6,55,244
10/26/10 1,85,800.00 -1.80% 4,22,484
09/26/09 1,89,200.00 +6.53% 9,08,714
06/26/06 1,77,600.00 -4.57% 8,03,326
05/26/05 1,86,100.00 -3.37% 7,53,929
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1,85,800.00KRW
Average target price
1,83,200.00KRW
Spread / Average Target
-1.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A298380 Stock